Aegerion

A biopharmaceutical company that develops innovative drugs to treat rare diseases

placeCambridge, Massachusetts, United States calendar_todayFounded 2005 groups63 employees language aegerion.com

Registered entities

Investor mix

12 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital433%
Private equity433%
Bank & private debt18%
Other / undisclosed325%
Coming soon